Items where authors include "Dai, Wei Fang"

Article

Dai, Wei Fang, Beca, Jaclyn M, Nagamuthu, Chenthila et al. (5 more authors) (2022) Cost-effectiveness Analysis of Pertuzumab With Trastuzumab in Patients With Metastatic Breast Cancer. JAMA Oncology. pp. 597-606. ISSN 2374-2445

Dai, Wei Fang, de Oliveira, Claire orcid.org/0000-0003-3961-6008, Blommaert, Scott et al. (24 more authors) (2022) Mapping Canadian Data Assets to Generate Real-World Evidence : Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s RWE Data Working Group. Current Oncology. pp. 2046-2063. ISSN 1718-7729

Dai, Wei Fang, Beca, Jaclyn M, Nagamuthu, Chenthila et al. (6 more authors) (2022) Comparative Effectiveness and Safety of Pertuzumab and Trastuzumab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy for Treatment of Metastatic Breast Cancer. JAMA network open. e2145460. ISSN 2574-3805

Chan, Kelvin, Nam, Seungree, Evans, Bill et al. (9 more authors) (2020) Developing a framework to incorporate real-world evidence in cancer drug funding decisions : The Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration. BMJ Open. e032884. ISSN 2044-6055